A Novel Combination of Bevacizumab and Pembrolizumab Stimulates Tumour Immunity Through Vascular Normalisation in Humanised Mouse Model
Tianyun Qiao(Air Force Medical University), Yong Hwan Han(Mayo Clinic in Florida)
Cited by 1
Related Papers
Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model
|Frontiers in Oncology|2021|106